<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Yet, in within-group analysis, a significant increase was observed after intervention compared to baseline considering the serum levels of CAT in group 2 (mean difference (MD) = 8.6; CI 95% = 1.9–15.2, 
 <italic class="italic">p</italic> = 0.014) and group 3 (MD = 12.8; CI 95% = 6.5–19.1, 
 <italic class="italic">p</italic> &lt; 0.001), GPx in group 2 (MD = 1063.3; CI 95% = 509.7–1616.9, 
 <italic class="italic">p</italic> &lt; 0.001) and group 3 (MD = 1682.3; CI 95% = 794.3–2570.3, 
 <italic class="italic">p</italic> &lt; 0.001), and SOD in group 2 (MD = 49.2; CI 95% = 29.1–69.2, 
 <italic class="italic">p</italic> &lt; 0.001) and group 3 (MD = 54.1; CI 95% = 27.4–80.8, 
 <italic class="italic">p</italic> &lt; 0.001). Meanwhile, serum levels of MDA in group 2 (MD = –0.4; CI 95% = −0.6 to −0.2, 
 <italic class="italic">p</italic> &lt; 0.001) and group 3 (MD = −0.3; CI 95% = −0.5 to −0.1, 
 <italic class="italic">p</italic> = 0.004) significantly decreased. Moreover, no significant difference was observed in group 1 in terms of CAT, SOD, and MDA levels (
 <italic class="italic">p</italic> &gt; 0.05) except for GPx level (MD= −52.3; CI 95% = −100.8 to –3.7, 
 <italic class="italic">p</italic> = 0.036), which reduced remarkably (
 <xref rid="biomolecules-09-00215-t004" ref-type="table" class="xref">Table 4</xref>).
</p>
